Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1

Enzo Ranierri, Rosemarie L. Gerace, Elaine M. Ravenscroft, John J. Hopwood, Peter J. Meikle

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We have demonstrated that the lysosome associated membrane protein (LAMP-1) is elevated in plasma from approximately 70% of lysosomal storage disorder patients. As part of the development of a newborn screening program for lysosomal storage disorders we have developed a first tier screening assay based upon the level of LAMP-I in blood spots taken from newborn Guthrie cards. To determine the effectiveness of the first-tier marker a prospective pilot Guthrie neonatal screening program for the identification of LSD was commenced in April 1998. Prior to commencement of the pilot program ethical approval was obtained and information leaflets regarding the neonatal screening of LSD were distributed to parents at the time of their infant's Guthrie collection. The LAMP-1 assay utilizes a chicken polyclonal and a mouse monoclonal in a sandwich time resolved fluorescent immunoassay. LAMP-1 blood-spot calibrators and quality control specimens were developed and shown to be stable and reproducible. To date 11,183 infants have been screened using LAMP-1. The population distribution is described with a median and 98th percentile of 220μg/l whole blood and 483μg/l whole blood respectively. Acceptable CV% for intra and inter assay of 8.9% and 10% respectively were obtained.

LanguageEnglish
Pages111-113
Number of pages3
JournalSoutheast Asian Journal of Tropical Medicine and Public Health
Volume30
Issue numberSUPPL. 2
Publication statusPublished - 1 Dec 1999
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Ranierri, E., Gerace, R. L., Ravenscroft, E. M., Hopwood, J. J., & Meikle, P. J. (1999). Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1. Southeast Asian Journal of Tropical Medicine and Public Health, 30(SUPPL. 2), 111-113.
Ranierri, Enzo ; Gerace, Rosemarie L. ; Ravenscroft, Elaine M. ; Hopwood, John J. ; Meikle, Peter J. / Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1. In: Southeast Asian Journal of Tropical Medicine and Public Health. 1999 ; Vol. 30, No. SUPPL. 2. pp. 111-113.
@article{a520a334e9824101b914016d08dc859d,
title = "Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1",
abstract = "We have demonstrated that the lysosome associated membrane protein (LAMP-1) is elevated in plasma from approximately 70{\%} of lysosomal storage disorder patients. As part of the development of a newborn screening program for lysosomal storage disorders we have developed a first tier screening assay based upon the level of LAMP-I in blood spots taken from newborn Guthrie cards. To determine the effectiveness of the first-tier marker a prospective pilot Guthrie neonatal screening program for the identification of LSD was commenced in April 1998. Prior to commencement of the pilot program ethical approval was obtained and information leaflets regarding the neonatal screening of LSD were distributed to parents at the time of their infant's Guthrie collection. The LAMP-1 assay utilizes a chicken polyclonal and a mouse monoclonal in a sandwich time resolved fluorescent immunoassay. LAMP-1 blood-spot calibrators and quality control specimens were developed and shown to be stable and reproducible. To date 11,183 infants have been screened using LAMP-1. The population distribution is described with a median and 98th percentile of 220μg/l whole blood and 483μg/l whole blood respectively. Acceptable CV{\%} for intra and inter assay of 8.9{\%} and 10{\%} respectively were obtained.",
author = "Enzo Ranierri and Gerace, {Rosemarie L.} and Ravenscroft, {Elaine M.} and Hopwood, {John J.} and Meikle, {Peter J.}",
year = "1999",
month = "12",
day = "1",
language = "English",
volume = "30",
pages = "111--113",
journal = "Southeast Asian Journal of Tropical Medicine and Public Health",
issn = "0125-1562",
publisher = "Southeast Asian Ministers of Education Organisation",
number = "SUPPL. 2",

}

Ranierri, E, Gerace, RL, Ravenscroft, EM, Hopwood, JJ & Meikle, PJ 1999, 'Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1', Southeast Asian Journal of Tropical Medicine and Public Health, vol. 30, no. SUPPL. 2, pp. 111-113.

Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1. / Ranierri, Enzo; Gerace, Rosemarie L.; Ravenscroft, Elaine M.; Hopwood, John J.; Meikle, Peter J.

In: Southeast Asian Journal of Tropical Medicine and Public Health, Vol. 30, No. SUPPL. 2, 01.12.1999, p. 111-113.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1

AU - Ranierri, Enzo

AU - Gerace, Rosemarie L.

AU - Ravenscroft, Elaine M.

AU - Hopwood, John J.

AU - Meikle, Peter J.

PY - 1999/12/1

Y1 - 1999/12/1

N2 - We have demonstrated that the lysosome associated membrane protein (LAMP-1) is elevated in plasma from approximately 70% of lysosomal storage disorder patients. As part of the development of a newborn screening program for lysosomal storage disorders we have developed a first tier screening assay based upon the level of LAMP-I in blood spots taken from newborn Guthrie cards. To determine the effectiveness of the first-tier marker a prospective pilot Guthrie neonatal screening program for the identification of LSD was commenced in April 1998. Prior to commencement of the pilot program ethical approval was obtained and information leaflets regarding the neonatal screening of LSD were distributed to parents at the time of their infant's Guthrie collection. The LAMP-1 assay utilizes a chicken polyclonal and a mouse monoclonal in a sandwich time resolved fluorescent immunoassay. LAMP-1 blood-spot calibrators and quality control specimens were developed and shown to be stable and reproducible. To date 11,183 infants have been screened using LAMP-1. The population distribution is described with a median and 98th percentile of 220μg/l whole blood and 483μg/l whole blood respectively. Acceptable CV% for intra and inter assay of 8.9% and 10% respectively were obtained.

AB - We have demonstrated that the lysosome associated membrane protein (LAMP-1) is elevated in plasma from approximately 70% of lysosomal storage disorder patients. As part of the development of a newborn screening program for lysosomal storage disorders we have developed a first tier screening assay based upon the level of LAMP-I in blood spots taken from newborn Guthrie cards. To determine the effectiveness of the first-tier marker a prospective pilot Guthrie neonatal screening program for the identification of LSD was commenced in April 1998. Prior to commencement of the pilot program ethical approval was obtained and information leaflets regarding the neonatal screening of LSD were distributed to parents at the time of their infant's Guthrie collection. The LAMP-1 assay utilizes a chicken polyclonal and a mouse monoclonal in a sandwich time resolved fluorescent immunoassay. LAMP-1 blood-spot calibrators and quality control specimens were developed and shown to be stable and reproducible. To date 11,183 infants have been screened using LAMP-1. The population distribution is described with a median and 98th percentile of 220μg/l whole blood and 483μg/l whole blood respectively. Acceptable CV% for intra and inter assay of 8.9% and 10% respectively were obtained.

UR - http://www.scopus.com/inward/record.url?scp=0033302657&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 111

EP - 113

JO - Southeast Asian Journal of Tropical Medicine and Public Health

T2 - Southeast Asian Journal of Tropical Medicine and Public Health

JF - Southeast Asian Journal of Tropical Medicine and Public Health

SN - 0125-1562

IS - SUPPL. 2

ER -

Ranierri E, Gerace RL, Ravenscroft EM, Hopwood JJ, Meikle PJ. Pilot neonatal screening program for lysosomal storage disorders, using LAMP-1. Southeast Asian Journal of Tropical Medicine and Public Health. 1999 Dec 1;30(SUPPL. 2):111-113.